7808 logo

BIONET Therapeutics Corp. Stock Price

TPEX:7808 Community·NT$4.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

7808 Share Price Performance

NT$59.80
5.30 (9.72%)
NT$59.80
5.30 (9.72%)
Price NT$59.80

7808 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks
1 Reward

BIONET Therapeutics Corp. Key Details

NT$105.7m

Revenue

NT$85.4m

Cost of Revenue

NT$20.2m

Gross Profit

NT$120.7m

Other Expenses

-NT$100.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-1.44
19.15%
-95.07%
0%
View Full Analysis

About 7808

Founded
2022
Employees
73
CEO
Cheng-Hsien Tsai
WebsiteView website
www.bionettx.com

BIONET Therapeutics Corp., a biopharmaceutical company, develops cell therapy products and drug development for acute and severe diseases. The company develops treatment for adult respiratory distress syndrome, pulmonary fibrosis, chronic kidney failure, acute wound healing, chronic wound healing of diabetic ulcers, osteoarthritis, and dry eye syndrome. It also provides CRDMO services. The company was founded in 2022 and is based in Taipei, Taiwan.

Recent 7808 News & Updates

Recent updates

No updates